FDA to improve access to experimental cancer drugs

Thousands of gravely ill cancer patients each year seek "compassionate use" access to treatments that are not yet on the market, but have shown some promise in early testing and aren't available to them through a study. The government wants to make that access easier and give more heft to the requests.